Skip to main content
Neural Therapeutics Inc. logo

Neural Therapeutics Inc. — Investor Relations & Filings

Ticker · NURL ISIN · CA64134N2032 LEI · 894500KBZO3KS9715774 CSE Manufacturing
Open in API
Filings indexed 141 across all filing types
Latest filing 2024-06-21 Interim / Quarterly Rep…
Country CA Canada
Listing CSE NURL

About Neural Therapeutics Inc.

https://neuraltherapeutics.ca/

Neural Therapeutics Inc. is an ethnobotanical drug discovery and development company operating in the pharmaceutical and nutraceutical sectors. It focuses on developing therapeutic drugs for mental illnesses, including those related to substance abuse, and over-the-counter dietary supplements. The company integrates modern scientific research with traditional indigenous knowledge regarding psychoactive plants and whole plant extracts. Initial R&D centers on the San Pedro cactus (Echinopsis pachanoi), which contains mescaline. Neural Therapeutics pursues a dual-path strategy to develop both pharmaceutical and nutraceutical products, aiming for whole plant utilization and zero waste.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Interim Management's Discussion and Analysis of Financial Condition and Results of Operations for the Nine Months Ended April 30, 2024' and is dated June 20, 2024. It contains detailed management discussion and analysis (MD&A) of the company's financial condition and operational results for an interim period (nine months ended April 30, 2024). The text references compliance with National Instrument 51-102, which governs continuous disclosure obligations including MD&A filings. It includes forward-looking statements, corporate overview, business description, financial highlights, and management commentary. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content matches the definition of an Interim / Quarterly Report (IR), which includes comprehensive financial report for a period shorter than a full fiscal year with substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. 9M 2024
2024-06-21 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Interim Condensed Financial Statements' for the three and nine months ended April 30, 2024. It contains detailed financial statements including statements of loss, comprehensive loss, changes in shareholders' deficit, notes on nature of operations, basis of preparation, accounts payable, share capital, and other financial disclosures. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of interim financial statements and the reference to IAS 34 (Interim Financial Reporting) confirms this is a quarterly or interim report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-06-21 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a detailed exploration update from Chakana Copper Corp. It reports drilling results, mineralized intercepts, and exploration progress at the Soledad project. The content focuses on exploration data, assay results, geological descriptions, and technical details about mineralization. There is no indication that this is a financial report, earnings release, or regulatory filing. It is not an announcement of a report publication but rather a substantive update on exploration activities and results. This type of document is typical of a Capital/Financing Update (CAP) or an Exploration Update, but since it primarily reports exploration results and progress rather than financial or capital structure changes, the best fit is Capital/Financing Update (CAP) as it relates to ongoing project development and funding status mentioned in the text (e.g., fully funded drill program). The document is not a formal Annual Report, Interim Report, or Earnings Release, nor does it fit other categories like M&A, Legal, or Governance. Therefore, the classification is CAP with high confidence.
2024-05-08 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended January 31, 2024. The text explicitly states it is a certification letter and does not contain actual financial data or the interim report itself. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR). The document length is short (2983 characters), and it is a certification rather than the report itself.
2024-03-29 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CFO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended January 31, 2024. The text explicitly states it is a certification letter and does not contain actual financial data or the interim report itself. According to the CERTIFICATION RULE, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR). The document length is short (2986 characters), consistent with a certification letter rather than a full interim report.
2024-03-29 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Interim Management's Discussion and Analysis of Financial Condition and Results of Operations for the Six Months Ended January 31, 2024' and contains detailed management discussion and analysis (MD&A) for a six-month interim period. It includes financial and business highlights, corporate overview, forward-looking statements, and significant transactions during the period. The document is prepared in compliance with National Instrument 51-102 and references unaudited condensed consolidated interim financial statements prepared under IFRS. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement. The content matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. H1 2024
2024-03-29 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.